[Efficacy of intravenous administration of atrial natriuretic peptide after cardiac surgery in neonates and infants].
Intravenous infusion of alpha-human atrial natriuretic polypeptide (hANP) and furosemide was performed in 12 patients (4: TGA, 3: univentricular heart, 3: HLHS, 2: VSD) after cardiopulmonary bypass. Their mean age at the operation was 68 days (6 patients in neonate), the mean body weight was 3.3 kg. All patients were treated with nitroglycerin in dose of 2 micrograms/kg/min and chlorpromazine in dose of 2.8 micrograms/kg/min and catecholamine in mean dose of 6.5 micrograms/kg/min. The criteria of indication for hANP was poor effect of furosemide alone. The hANP was given for 6-144 hours in dose of 0.1-0.2 microgram/kg/min. With the hANP and furosemide infusion, urine volume increased from 85.0 +/- 14.2 ml/kg/day to 107.9 +/- 25.3 ml/kg/day (p < 0.05), whereas the systemic arterial pressure, the central venous pressure and the renal function were unchanged. We conclude that the combination of the hANP and the furosemide is very effective in neonates and infants.
Murakami
E
E
Department of Cardiovascular Surgery, Fukuoka Children Hospital Medical Center, Japan.
Kado
H
H
Masuda
M
M
Shiokawa
Y
Y
Fukae
K
K
Kanegae
Y
Y
Iwaki
H
H
Shirota
T
T
Yasui
H
H
D009320:Atrial Natriuretic Factor / Q000008:administration & dosage*; D001794:Blood Pressure; D002315:Cardiopulmonary Bypass; D006330:Heart Defects, Congenital / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007668:Kidney / Q000503:physiopathology; D011182:Postoperative Care
D009320:Atrial Natriuretic Factor